Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Risk Assessment

View and export this data going back to 1996. Start your Free Trial

What is Apollo Hospitals Enterprise Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Apollo Hospitals Enterprise is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison of Apollo Hospitals Enterprise's Risk Assessment

For the Medical Care Facilities subindustry, Apollo Hospitals Enterprise's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apollo Hospitals Enterprise's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Apollo Hospitals Enterprise's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Apollo Hospitals Enterprise's Risk Assessment falls into.

Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Apollo Hospitals Enterprise Risk Assessment Related Terms

Thank you for viewing the detailed overview of Apollo Hospitals Enterprise's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Apollo Hospitals Enterprise Ltd (NSE:APOLLOHOSP) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

508869:India

Address

No. 8-17 Shafee Mohammed Road, Sunny Side Building, East Block, 3rd Floor, Chennai, TN, IND, 600 006

Website

https://www.apollohospitals.com

Apollo Hospitals Enterprise Ltd operates a network of private hospitals in India through primary, secondary, and tertiary care facilities. The firm's tertiary care hospitals provide complex care in a variety of specialties that include cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. Apollo Hospitals also operates primary care and diagnostics clinics as well as telemedicine units and offers consulting, health insurance, education and training, and research services. The firm receives the most proportion of revenue from its core healthcare business. The firm's standalone pharmacy segment contributes the second largest proportion of revenue.

Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Headlines

No Headlines